1. Modulating the Strength and Threshold of NOTCH Oncogenic Signals by mir-181a-1/b-1.
- Author
-
Fragoso, Rita, Tin Mao, Song Wang, Schaffert, Steven, Xue Gong, Sibiao Yue, Luong, Richard, Hyeyoung Min, Yumi Yashiro-Ohtani, Davis, Mark, Pear, Warren, and Chang-Zheng Chen
- Subjects
ONCOGENES ,TUMOR growth ,CANCER treatment ,CANCER genetics ,T cell receptors - Abstract
Oncogenes, which are essential for tumor initiation, development, and maintenance, are valuable targets for cancer therapy. However, it remains a challenge to effectively inhibit oncogene activity by targeting their downstream pathways without causing significant toxicity to normal tissues. Here we show that deletion of mir-181a-1/b-1 expression inhibits the development of Notch1 oncogene-induced T cell acute lymphoblastic leukemia (T-ALL). mir-181a-1/b-1 controls the strength and threshold of Notch activity in tumorigenesis in part by dampening multiple negative feedback regulators downstream of NOTCH and pre-T cell receptor (TCR) signaling pathways. Importantly, although Notch oncogenes utilize normal thymic progenitor cell genetic programs for tumor transformation, comparative analyses of mir-181a-1/b-1 function in normal thymocyte and tumor development demonstrate that mir-181a-1/b-1 can be specifically targeted to inhibit tumor development with little toxicity to normal development. Finally, we demonstrate that mir-181a-1/b-1, but not mir-181a-2b-2 and mir-181-c/d, controls the development of normal thymic T cells and leukemia cells. Together, these results illustrate that NOTCH oncogene activity in tumor development can be selectively inhibited by targeting the molecular networks controlled by mir-181a-1/b-1. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF